Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Prevail Global Study [NA]

View source ↗

Summary

This document reports that the Prevail Global Study by Medtronic Vascular is currently recruiting participants for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Medtronic Vascular Prevail Global Study

Snippet

Sponsor: Medtronic Vascular | Conditions: Coronary Artery Disease | NA | Status: RECRUITING